OP-137 [AJC » Coronary stents and advances in stent technology] Red Cell Distribution Width and Neutrophil/Lymphocyte Ratio in Coronary Bare Metal Stent Restenosis

OP-137 [AJC » Coronary stents and advances in stent technology] Red Cell Distribution Width and Neutrophil/Lymphocyte Ratio in Coronary Bare Metal Stent Restenosis

Despite promising improvements in stent technology, the optimum treatment strategy for patients requiring coronary artery stenting is still not fully understood, due particularly to the difficulty to predict which patients will develop in-stent restenosis. Different from in-stent restenosis group Co...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology Vol. 119; no. 8; p. e46
Main Authors: Yilmaz, Kerem Can, Ciftci, Orcun, Karacaglar, Emir, Bal, Ugur Abbas, Okyay, Kaan, Aydinalp, Alp, Yildirir, Aylin, Müderrisoglu, İbrahim Haldun
Format: Journal Article
Language:English
Published: New York Elsevier Inc 15-04-2017
Elsevier Limited
Subjects:
Acute coronary syndromes
Cardiovascular
Cardiovascular disease
Coronary artery
Coronary vessels
Implants
Lymphocytes
Medical imaging
Neutrophils
Patients
Restenosis
Stents
Surgical implants
Technology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Despite promising improvements in stent technology, the optimum treatment strategy for patients requiring coronary artery stenting is still not fully understood, due particularly to the difficulty to predict which patients will develop in-stent restenosis. Different from in-stent restenosis group Control Groupn=60 Without stent restenosisn=60 With stent restenosisn=31 p value RDW 15.2 ± 1.2 (13.8-20.7) b,c 15.5 ± 1.2 (12.9 ± 20.4) a 16.0 ± 1.6 (12.6-20.1) a 0.025 Neutrophil count (x109/L) 4.30 ± 1.33 (1.89-9.07)...
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2017.03.140